Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Acyclic And Carbocyclic Compounds In Medicinal Compositions
(AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
Human malaria, especially malignant tertian malaria, can be success-fully treated by the combined administration of an iron(III) chelating agent selected from the class consisting of desferriox-amine B and desferriferrithiocine and the pharmacologically effective derivatives, thereof as component A, and a conventional antimalarial agent selected from the schizontocides as component B, in a synergistically effective retio, this therapy is especially advantageous for combating chloroquine-resistant strains of plasmodium falciparum
JO19871462A1987-04-261987-04-26combination preparation for the treatment of malaria
JO1462B1
(en)
Halomethylidene derivatives and method of treating cancer by conjunctive therapy with 2'-halomethylidene derivatives and a s-phase or m-phase specific antineoplastic agent